Search Form
First, enter a politician or zip code
Now, choose a category
 

Frank Pallone, Jr.'s Public Statements on Issue: Drugs

Office: U.S. House (NJ) - District 6, Democratic
Date Title
May 19, 2017 Letter to the Hon. Mick Mulvaney, Director of the office of Managament and Budget - Urging Administration to Maintain Anti-Drug-Funding
May 16, 2017 Letter to the Hon. Mick Mulvaney, Director of the Office of Management and Budget- Reductions to the Office of the National Drug Control Policy
May 8, 2017 Letters to AmerisourceBergen Corporation, CardinalHealth, McKesson Corporation and the Drug Enforcement Administration - Alleged Pill Dumping in West Virginia
May 8, 2017 Letters to the AmerisourceBergen Corporation, CardinalHealth, McKesson Corporation, and the Drug Enforcement Administration - Alleged Pill Dumping in West Virginia
Feb. 23, 2017 Letter to Mr. Kemp Chester, Acting Director of the the Office of National Dug Control Policy - Provide Assistance in Questioning all Federal Agencies on Plans to Address Fentanyl
May 4, 2016 Letter to the Hon. Paul Ryan, Speaker of the House - Consider Emergency Funding To Address Opioid And Heroin Epidemic
July 7, 2015 Letter to Stephen Ostroff, Acting Commissioner of the Food and Drug Administration - Opioid Abuse Epidemic
Oct. 9, 2012 Letter to Chairman Upton, Chairman Pitts, and Chairman Stearns
Feb. 23, 2012 Letter to Margaret Hamburg, the Commissioner of the Food and Drug Administration
March 24, 2011 Letter to Mr. Gregory J. Divis President Ther-Rx Corporation Chief Executive Officer KV Pharmaceutical Company
March 4, 2011 Letter to The Honorable Joseph R. Pitts Chairman Subcommittee on Health
Sept. 24, 2010 Pallone Requests Thorough Review of FDA's Approval of Genetically Engineered Salmon
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top